Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Alz-tau Biomarker for Alzheimer’s Disease: Study in a Caucasian Population

11 Feb 2019

Abstract excerpt

The establishment of a molecular biomarker for early detection of Alzheimer's disease (AD) is critical for diagnosis and follow up of patients, and as a quantitative parameter in the evaluation of potential new drugs to control AD. A list of blood biomarkers has been reported but none has been validated for the Alzheimer's clinic. The changes in hyperphosphorylated tau and amyloid peptide in the cerebrospinal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30775977
DOI: 10.3233/jad-180637

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Alz-tau Biomarker for Alzheimer’s Disease: Study in a Caucasian PopulationPMID 30775977Read ↗

Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer's Disease.Semantic proximity Read ↗

Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent InsightsSemantic proximity Read ↗

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's diseaseSemantic proximity Read ↗

Correlation analysis of peripheral platelet markers and disease phenotypes in Alzheimer's disease.Semantic proximity Read ↗

Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinicsSemantic proximity Read ↗

[Biomarkers in Alzheimer's disease].Semantic proximity Read ↗

Innovative Biomarkers for Alzheimer’s Disease: Focus on the Hidden Disease BiomarkersSemantic proximity Read ↗

[Cerebrospinal fluid markers in early diagnosis of Alzheimer dementia].Semantic proximity Read ↗

Can peripheral leukocytes be used as Alzheimer's disease biomarkers?Semantic proximity Read ↗

Marking the markers of Alzheimer's: too good to diagnose, too bad to use?Semantic proximity Read ↗

Blood biomarkers for Alzheimer’s disease with the Lumipulse automated platform: Age-effect and clinical value interpretationSemantic proximity Read ↗

Platelet-to-lymphocyte ratio correlates with mild cognitive impairment and the hippocampal atrophySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.